Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.
about
Conformational variation of an extreme drug resistant mutant of HIV protease.Recent Developments and Applications of the MMPBSA Method.Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death.Fast and accurate determination of the relative binding affinities of small compounds to HIV-1 protease using non-equilibrium work.
P2860
Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exploring the drug resistance ...... ynamics and binding mechanism.
@ast
Exploring the drug resistance ...... ynamics and binding mechanism.
@en
type
label
Exploring the drug resistance ...... ynamics and binding mechanism.
@ast
Exploring the drug resistance ...... ynamics and binding mechanism.
@en
prefLabel
Exploring the drug resistance ...... ynamics and binding mechanism.
@ast
Exploring the drug resistance ...... ynamics and binding mechanism.
@en
P2860
P1476
Exploring the drug resistance ...... ynamics and binding mechanism.
@en
P2093
Biswa Ranjan Meher
Yixuan Wang
P2860
P356
10.1016/J.JMGM.2014.11.003
P577
2014-12-05T00:00:00Z